Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 11 studies | 41% ± 15% | |
| basal cell | 9 studies | 26% ± 8% | |
| ciliated cell | 9 studies | 28% ± 8% | |
| respiratory goblet cell | 7 studies | 33% ± 16% | |
| secretory cell | 7 studies | 30% ± 10% | |
| goblet cell | 7 studies | 34% ± 7% | |
| enterocyte | 6 studies | 29% ± 8% | |
| plasmacytoid dendritic cell | 6 studies | 23% ± 4% | |
| ionocyte | 5 studies | 55% ± 14% | |
| myeloid cell | 5 studies | 18% ± 2% | |
| squamous epithelial cell | 4 studies | 52% ± 16% | |
| transit amplifying cell | 4 studies | 24% ± 6% | |
| brush cell | 4 studies | 25% ± 5% | |
| club cell | 3 studies | 34% ± 5% | |
| conventional dendritic cell | 3 studies | 24% ± 6% | |
| intestinal crypt stem cell | 3 studies | 24% ± 6% | |
| macrophage | 3 studies | 18% ± 1% | |
| type I pneumocyte | 3 studies | 23% ± 5% | |
| dendritic cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 5693.76 | 328 / 328 | 97% | 308.85 | 173 / 178 |
| thymus | 100% | 5369.84 | 652 / 653 | 96% | 207.29 | 579 / 605 |
| lung | 94% | 3289.94 | 544 / 578 | 98% | 242.53 | 1127 / 1155 |
| prostate | 89% | 4155.66 | 217 / 245 | 99% | 260.51 | 498 / 502 |
| stomach | 76% | 4413.37 | 272 / 359 | 98% | 388.06 | 279 / 286 |
| breast | 62% | 2362.58 | 285 / 459 | 95% | 151.66 | 1062 / 1118 |
| kidney | 100% | 6591.87 | 89 / 89 | 54% | 111.69 | 487 / 901 |
| intestine | 54% | 11319.13 | 520 / 966 | 98% | 484.73 | 519 / 527 |
| bladder | 52% | 1868.76 | 11 / 21 | 95% | 335.30 | 480 / 504 |
| esophagus | 39% | 5804.27 | 568 / 1445 | 97% | 245.07 | 178 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 224.62 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 197.59 | 1 / 1 |
| ovary | 3% | 26.02 | 5 / 180 | 97% | 216.05 | 417 / 430 |
| uterus | 7% | 271.58 | 12 / 170 | 86% | 248.98 | 395 / 459 |
| spleen | 83% | 1472.76 | 199 / 241 | 0% | 0 | 0 / 0 |
| skin | 72% | 5596.92 | 1305 / 1809 | 6% | 5.43 | 26 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 144.99 | 21 / 29 |
| liver | 20% | 283.92 | 45 / 226 | 32% | 47.86 | 131 / 406 |
| peripheral blood | 46% | 870.01 | 427 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 30% | 353.67 | 77 / 258 | 1% | 0.63 | 2 / 230 |
| adipose | 21% | 440.28 | 255 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 9% | 150.09 | 114 / 1335 | 0% | 0 | 0 / 0 |
| brain | 1% | 12.48 | 22 / 2642 | 3% | 1.92 | 18 / 705 |
| heart | 1% | 8.64 | 6 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 2.93 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030216 | Biological process | keratinocyte differentiation |
| GO_0006508 | Biological process | proteolysis |
| GO_0001843 | Biological process | neural tube closure |
| GO_0030163 | Biological process | protein catabolic process |
| GO_0060672 | Biological process | epithelial cell morphogenesis involved in placental branching |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0008236 | Molecular function | serine-type peptidase activity |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | ST14 |
| Protein name | ST14 protein Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein) |
| Synonyms | SNC19 PRSS14 TADG15 |
| Description | FUNCTION: Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site . Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing . Proteolytically cleaves and therefore activates TMPRSS13 . . |
| Accessions | ENST00000278742.6 Q8WVC1 Q9Y5Y6 |